1. The Value of Anti-angiogenics in Bladder Cancer Therapy
   Gerald Bastian Schulz et al, 2019, Tumor Angiogenesis CrossRef
2. Endothelin B Receptor, a New Target in Cancer Immune Therapy
   Lana E. Kandalaft et al, 2009, Clinical Cancer Research CrossRef
3. Endothelin-1 Stimulates Lymphatic Endothelial Cells and Lymphatic Vessels to Grow and Invade
   Francesca Spinella et al, 2009, Cancer Research CrossRef
4. Endothelin-1 indicates unfavorable prognosis in primary high-grade non-muscle-invasive urothelial bladder cancer
   Lampros Mitrakas et al, 2021, Archivio Italiano di Urologia e Andrologia CrossRef
5. The Value of Anti-angiogenics in Bladder Cancer Therapy
   Gerald Bastian Schulz et al, 2017, Tumor Angiogenesis CrossRef